USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα.
Zhuang T, Zhang S, Liu D, Li Z, Li X, Li J, Yang P, Zhang C, Cui J, Fu M, et al. J Exp Clin Cancer Res. 2024 Aug 31; 43(1):249. Epub 2024 Aug 31.